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The availability of free iron in vivo is strictly limited, in part by the iron-binding protein transferrin. The
pathogenic Neisseria spp. can sequester iron from this protein, dependent upon two iron-repressible, trans-
ferrin-binding proteins (TbpA and TbpB). TbpA is a TonB-dependent, integral, outer membrane protein that
may form a b-barrel exposing multiple surface loops, some of which are likely to contain ligand-binding motifs.
In this study we propose a topological model of gonococcal TbpA and then test some of the hypotheses set forth
by the model by individually deleting three putative loops (designated loops 4, 5, and 8). Each mutant TbpA
could be expressed without toxicity and was surface exposed as assessed by immunoblotting, transferrin
binding, and protease accessibility. Deletion of loop 4 or loop 5 abolished transferrin binding to whole cells in
solid- and liquid-phase assays, while deletion of loop 8 decreased the affinity of the receptor for transferrin
without affecting the copy number. Strains expressing any of the three mutated TbpAs were incapable of growth
on transferrin as a sole iron source. These data implicate putative loops 4 and 5 as critical determinants for
receptor function and transferrin-iron uptake by gonococcal TbpA. The phenotype of the DL8TbpA mutant
suggests that high-affinity ligand interaction is required for transferrin-iron internalization.
Neisseria gonorrhoeae is the causative agent of the sexually
transmitted disease gonorrhea, which has an annual incidence
rate of more than 62 million cases worldwide (53). While
frequently asymptomatic, gonococcal infection can be associ-
ated with serious sequelae, including salpingitis, endometritis,
ectopic pregnancy, and infertility in women (49). In addition,
gonococcal disease enhances the human immunodeficiency vi-
rus titer in seminal plasma of coinfected men, presumably
increasing the likelihood of disease transmission (11). In light
of these factors, compounded by increased antibiotic resistance
(25) and the lack of an effective vaccine, gonorrhea remains a
serious public health problem.
Iron is an essential nutrient for all microorganisms (21);
however, free iron is rare in the human body, generally being
complexed by a number of high-affinity binding proteins, in-
cluding transferrin (Tf) in plasma and lactoferrin in secretions
and macrophages (9). A total of 100% of clinical isolates of N.
gonorrhoeae can obtain iron from human Tf (40), while ap-
proximately 50% of gonococcal isolates can obtain iron from
human lactoferrin (39). The ability to use human proteins as
iron sources may allow the gonococcus to overcome bacterio-
static iron limitation, which is typical in vivo (9). In contrast to
other bacteria, the Tf-iron uptake system employed by patho-
genic neisseriae is siderophore independent (3), relying instead
on direct association between a surface-exposed bacterial re-
ceptor and ligand (3, 48). The receptor is specific for human Tf
(31, 32), and Tf-iron internalization is energy (38) and Ton (5,
14) dependent.
The gonococcal Tf receptor is composed of two iron-regu-
lated, Tf-binding proteins designated TbpA and TbpB (14).
TbpA is highly conserved among the pathogenic neisseriae
(12) and is a member of the TonB-dependent family of integral
outer membrane proteins (16). Consistent with other proteins
within this group (27, 34, 44), TbpA is likely to form a TonB-
regulated transmembrane b-barrel, through which iron can
enter the periplasm. Recent crystallographic analyses of FhuA
(35) and FepA (8) have demonstrated the involvement of sur-
face-exposed loops in ligand binding. In addition, these studies
demonstrated that FhuA and FepA each have an amino-ter-
minal globular domain, which serves as a “plug” in the interior
of the transmembrane pore (35). This domain was found to
contain a conserved pentameric sequence referred to as the
“TonB box” (46), a region that has been shown to interact with
the energy transducer TonB (4, 10, 23, 30, 45). Thus, it is
probable that the TonB box of TbpA likewise interacts with the
periplasmic protein TonB, thereby energizing the Tf receptor
and enabling iron internalization.
TbpB is more variable than TbpA, with molecular masses
that range from 78 to 86 kDa in N. gonorrhoeae (2, 13) and
from 65 to 85 kDa in N. meningitidis (33, 43, 47). TbpB is
lipidated and exposed on the outer leaflet of the bacterial outer
membrane (2, 33). Although both Tbps specifically and inde-
pendently bind human Tf, TbpB selectively binds the ferrated
form of this protein while TbpA binds both ferrated and apo Tf
(7, 18).
Efficient utilization of Tf as a sole iron source requires ex-
pression of both gonococcal Tbps (2). A gonococcal mutant
lacking TbpB exhibited decreased Tf-iron internalization rel-
ative to the wild-type strain, suggesting that while TbpB ex-
pression increases the efficiency of the receptor, it is not es-
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sential for Tf-iron internalization (2). In contrast, expression of
TbpA is absolutely required for Tf-iron growth and Tf-iron
internalization (16), consistent with its role as a transmem-
brane pore for Tf bound iron. Cornelissen and Sparling (18)
demonstrated that TbpA and TbpB are in close proximity to
one another and may interact, at least transiently, on the sur-
face of intact gonococci. Surface exposure and Tf-binding char-
acteristics of the cell-associated TbpA-TbpB complex are de-
pendent upon a wild-type Ton system and TonB-box at the
amino terminus of TbpA (14).
In this study, we propose a model of gonococcal TbpA that
combines computer analysis with observed sequence conserva-
tion among TonB-dependent receptors and sequence diversity
among gonococcal TbpA sequences. We suggest that TbpA
may form a b-barrel composed of 22 transmembrane strands
and probably has a periplasmic globular domain equivalent to
that described for FhuA (35) and FepA (8). We have tested
aspects of this model by individually deleting three regions of
gonococcal TbpA, each predicted to form an extracellular,
surface-exposed loop. We assessed the surface exposure and
function of these deletion derivatives of TbpA and determined
that, while expression of loops 4 and 5 of TbpA was critical for
the Tf-binding function of this receptor, expression of loop 8
was required for optimal ligand interaction.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial strains and plasmids
used in this study are described in Table 1. Unless otherwise stated, gonococci
were grown on plates containing GC medium base (Difco) with Kellogg’s sup-
plement I (1%) (26) and 12 mM Fe(NO3)3 in a 5% CO2 atmosphere at 35°C. For
growth in iron-stressed conditions, gonococci were cultured in liquid CDM
medium (51) which was pretreated with Chelex-100 (Bio-Rad) to remove resid-
ual iron. CDM-agarose plates containing 2.5 mM Tf (30% iron saturated) were
used to assess the ability of gonococcal strains to utilize Tf-bound iron. Plasmids
were propagated in Escherichia coli strains (Table 1) cultured on Luria-Bertani
plates (37) containing appropriate antibiotics (50 mg of ampicillin or kanamycin
per ml).
Standard recombinant DNA techniques and DNA sequencing. Isolation of
plasmid DNA, digestion with restriction endonucleases and subsequent ligation
were carried out according to manufacturer’s recommendations. PCR amplifi-
cation was carried in standard conditions (Gibco-BRL) with annealing temper-
atures optimized for each set of oligonucleotide primers. DNA was sequenced
using a 377 DNA sequencer (Applied Biosystems) at the Virginia Common-
wealth University Nucleic Acids Core Facility. The template was supplied as
plasmid DNA, purified using the Wizard Mini-Prep system (Promega). Nucleo-
tide positions are numbered in accordance with the gonococcal tbpA sequence
from strain FA19 deposited in GenBank under the accession no. M96731 (16).
Gonococcal transformation. Mutated tbpA genes were transformed into gono-
coccal strains according to the method described by Gunn and Stein (22). Briefly,
piliated gonococci were resuspended in GC broth to a density of approximately
2 3 108 CFU/ml. Approximately 100 CFU were spotted onto GC agar plates,
followed immediately by linearized plasmid preparations, which had been puri-
fied using the Wizard DNA clean-up kit (Promega). Following overnight growth,
individual colonies were subcultured and then screened for the incorporation
tbpA mutations into the chromosome. This analysis involved subjecting colony
lysates to PCR using oligonucleotide primers designed to amplify a diagnostic
product. Single colonies were passaged, and the genotype was confirmed by
DNA sequencing.
Solid-phase binding assays. Whole-cell binding analyses were carried out
using gonococci grown in iron-deficient, liquid CDM media as described above.
After 3 h of iron-limited growth, normalized amounts of culture were applied to
nitrocellulose filters. Blots were probed with horseradish peroxidase (HRP)-Tf (1
mg/ml) as described previously (6) and were developed with Opti-4-CN (Bio-
Rad) according to manufacturer’s recommendations. Duplicate blots were
probed using an anti-TbpA polyclonal serum raised against recombinant menin-
gococcal TbpA from strain SD (1), which cross-reacts with gonococcal TbpA.
This sera was preabsorbed against whole, iron-stressed gonococcal strain FA6747
(Table 1) to remove nonspecific, cross-reacting antibodies against antigens other
than TbpA. Dot blots were subsequently probed with a goat anti-rabbit immu-
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Description Source or reference
E. coli
DH5aMCR F2 mcrA D(mrr-hsdRMS-mcrBC) f80DlacZDM15 D(lacZYA-argF)U169
endA1 recA1 deoR thi-1 phoA supE441-gyrA96 relA1
Gibco-BRL
INVaF9 F9 endA1 recA1 hsdR17(rk
2, mk





FA6747 TbpA2 [tbpA::mTn3(cm)] 16
FA6905 TbpB2 (DtbpB) 18
FA6935 TbpA TonB-box mutant 14
FA6815 TbpA2 TbpB2 (tbpB::V) 2
MCV201 DL5TbpA This study
MCV202 DL5TbpA TbpB2 This study
MCV203 DL4TbpA This study
MCV204 DL4TbpA TbpB2 This study
MCV205 DL8TbpA This study




pCR2.1 Ampr Kanr Invitrogen
pUNCH412 pBSIISK(1) containing HindIII to XbaI fragment encoding TbpA 15
pVCU201 pCR2.1 containing 59 half of DL5tbpA (HindIII-BamHI) This study
pVCU204 pCR2.1 containing 39 half of DL5tbpA (BamHI-XhoI) This study
pVCU205 pET21 containing entire DL5tbpA (HindIII-XhoI) This study
pVCU206 pCR2.1 containing 59 half of DL4tbpA (HindIII-BamHI) This study
pVCU207 pCR2.1 containing 39 half of DL4tbpA (BamHI-XhoI) This study
pVCU208 pET21 containing entire DL4tbpA (HindIII-XhoI) This study
pVCU209 pCR2.1 containing 59 half of DL8tbpA (HindIII-BamHI) This study
pVCU210 pCR2.1 containing 39 half of DL8tbpA (BamHI-XhoI) This study
pVCU211 pET21 containing entire DL8tbpA (HindIII-XhoI) This study
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noglobulin G (IgG)-HRP conjugate and developed with Opti-4-CN (Bio-Rad)
according to the manufacturer’s recommendations.
Liquid-phase Tf-binding assay. Liquid-phase Tf-binding assays were per-
formed essentially as previously described (18). In these assays, iron-stressed
gonococci were mixed with various amounts of iodinated, iron-saturated Tf in the
presence or absence of unlabeled competitor Tf (iron saturated). After 20 min,
the unbound, iodinated Tf was removed by filtration through 0.45-mm-pore-size
nitrocellulose (Millipore Multi-Screen microtiter dish MAHV N45). The amount
of bound Tf was quantitated with a gamma scintillation counter. The binding
assays were standardized to whole-cell protein by performing protein assays
(bicinchoninic acid assay; Pierce) on iron-stressed cultures. Three identical ex-
periments, including growth and iron stress, were carried out; the datum points
represent the mean of three independent experiments. Specific binding was
calculated by subtracting nonspecific binding (detected in the presence of excess
competitor) from total counts for each Tf concentration. The specific activity of
the iodinated Tf was 1.61 3 106 cpm/mg. Copy number and Kd estimates were
obtained using Lundon software (Lundon Software) (36).
Protease-accessibility assay. Protease accessibility experiments were per-
formed as previously described (18). Briefly, iron-stressed whole gonococci
(grown in CDM) were treated with trypsin (Sigma-Aldrich) at concentrations of
0.5 to 2.5 mg/ml for 0 to 30 min. Proteolysis was stopped by addition of 0.6
trypsin-inhibiting units of aprotinin (Sigma-Aldrich), and whole-cell lysates were
prepared from samples taken at 10-min intervals. In some experiments, ferrated
Tf was added prior to protease exposure, to a final concentration of 100 nM.
Whole-cell proteins were resolved by sodium dodecyl-sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) using 7.5% acrylamide gels (29). Western blots
were probed with anti-TbpA polyclonal rabbit sera or with HRP-Tf (to detect
TbpB) according to previously described methods (18).
Immunofluorescence microscopy. Immunofluorescence microscopy was used
to confirm the surface exposure of TbpA on intact gonococci. Iron-stressed,
whole cells from gonococcal strains FA19 (positive control), FA6747 (negative
control), and MCV201 (Table 1) were mixed with dilutions anti-TbpA polyclonal
rabbit sera (raised against meningococcal TbpA from strain SD) (1) in the
presence of immunoglobulin-free bovine serum albumin (Sigma-Aldrich) as a
blocking reagent. Preimmune rabbit sera were also used as a negative control.
Unbound antibody was removed by centrifugation, and cells were then applied to
glass microscope slides and fixed by immersion in 100% methanol. These slides
were probed with goat anti-rabbit IgG conjugated to fluorescein isothiocyanate
(Sigma-Aldrich), and cells were counterstained with Eriochrome Black (Inte-
grated Diagnostics). Samples were visualized using an Olympus BHA micro-
scope equipped with a BH2RFL reflected fluorescence attachment and a PM-
10AD photomicrographic system (Olympus Corp).
RESULTS
Development of a topology model of gonococcal TbpA and
selection of loops for deletion analysis. We initially used the
method of Klebba et al. (28) to convert the TbpA sequence
into a two-dimensional topology model. We identified poten-
tial amphipathic b-strands with the algorithm MOMENT (19)
and putative b-turns with the algorithm bTURNPRED (52).
In addition, our original model located most stretches of hy-
drophilic residues and all six cysteine residues within predicted
surface-exposed loops. We modified this computer-generated
model by superimposing on it observed sequence variation
among TbpAs from the pathogenic neisseriae, Haemophilus
influenzae, Actinobacillus pleuropneumoniae, Pasteurella hae-
molytica, and Moraxella catarrhalis (12). We reasoned that se-
quence diversity would be enriched in surface-exposed regions
that were accessible to immune pressure and that conserved
domains would be either inaccessible or functionally con-
strained. Figure 1 represents the latest version of our TbpA
topology model and encompasses a further modification based
upon pairwise comparisons between TbpA and the recently
crystallized TonB-dependent receptor, FepA (8). Since the
coordinates of all FepA residues have been elucidated in the
crystal structure, we created a pairwise alignment between
gonococcal TbpA and FepA and used this alignment to iden-
tify putative b-strand endpoints. With this alignment, we also
identified an amino-terminal, 162-residue domain of TbpA
that was 29% identical and 44% similar to the analogous re-
gion of FepA. This amino-terminal region was shown in the
FepA crystal structure to form an essentially globular “plug”
that occludes the lumen of the b-barrel (8). We have depicted
the homologous region of TbpA (residues 1 to 162) in a similar
position in Fig. 1. This region is very well conserved among the
neisserial TbpAs (12), consistent with the suggestion that this
domain is inaccessible from the outside and therefore not
subject to immune pressure.
We generated a series of antipeptide sera against surface-
exposed loops predicted from our TbpA topology model (12).
One of these sera, directed against a portion of loop 5, reacted
with wild-type, surface-exposed TbpA (12). This observation
suggested that loop 5 was surface exposed, and thus we focused
initial deletion efforts on this loop. We chose to delete putative
loop 4 because it was situated next to loop 5 but, in contrast to
loop 5, was relatively well conserved in sequence among the
pathogenic neisseriae (12). We chose loop 8 for deletion anal-
ysis because it was divergent among the neisseriae and was
therefore likely to be surface exposed.
Construction of DL4TbpA, DL5TbpA, and DL8TbpA mu-
tants. The method for the construction of TbpA-encoding
plasmids from which loop 4 was deleted is schematically rep-
resented in Fig. 2. To delete loop 4 from TbpA of strain
FA19 (Table 1), we used the oligonucleotide pair HIND and
oVCU-16 to amplify the 59 half of tbpA; to amplify the 39 half
of tbpA, we used oVCU-17 and oVCU-7 (Table 2 and Fig. 2).
These oligonucleotides introduced novel BamHI sites flanking
the sequence that encodes loop 4. The separate PCR frag-
ments were cloned independently into pCR2.1, yielding
pVCU206 and pVCU207 (Table 1 and Fig. 2). Subsequently,
the 59 and 39 halves of tbpA were excised and cloned into the
pET21 expression vector in a single three-part ligation, pro-
ducing plasmid pVCU208 (Table 1 and Fig. 2). Sequence anal-
ysis confirmed the deletion of 144 bp of gonococcal tbpA in this
plasmid. The deleted region encoded 48 amino acids, which
were replaced by two residues: glycine and serine. However,
two additional single-base mutations were noted in the mu-
tated tbpA. The first was a silent mutation, and the second
exchanged an alanine for a glycine. Given the conservative
nature of these base changes, no corrective mutagenesis was
undertaken.
Construction and characterization of DL5tbpA and DL8tbpA
were carried out essentially as described above, substituting
oligonucleotides oVCU-16 and oVCU-17 with oLBAM and
oUBAM (Table 2), respectively, in the construction of DL5tbpA
and substituting oligonucleotides oVCU-16 and oVCU-17 with
oligonucleotides oVCU-25 and oVCU-24 (Table 2), respec-
tively, in the construction of DL8tbpA (Table 1). The 59 and 39
halves of DL5tbpA were cloned into pCR2.1, producing plas-
mids pVCU201 and pVCU204 (Table 1). Combining the in-
serts from these clones in pET21 generated plasmid pVCU205
(Table 1). Sequence analysis confirmed a deletion of 174 bp
within an otherwise-unaltered tbpA gene and established that
the 58 residues comprising loop 5 were replaced by a single
proline. The 59 and 39 halves of DL8tbpA were cloned into
pCR2.1, producing plasmids pVCU209 and pVCU210 (Table
1), respectively. Combining the inserts from these plasmids in
pET21 generated pVCU211 (Table 1). Sequence analysis of
this plasmid confirmed the deletion of 69 bp corresponding to
23 amino acids. This region was replaced by two residues
(glycine and serine), while the remaining TbpA sequence was
unaltered.
Following construction in E. coli, the plasmids encoding
DL4TbpA, DL5TbpA, and DL8TbpA were individually trans-
formed into gonococcal strains FA19 (wild type) and FA6905
(TbpB2), resulting in strains MCV201 through MCV206 (Ta-
ble 1). Following transformation, the regions surrounding each
deletion were PCR amplified from mutant chromosomes, the
products were sequenced, and no additional nucleotide
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changes were noted. This confirmed the successful incorpora-
tion of the mutant tbpA genes into the wild-type gonococcal
chromosome.
Solid-phase Tf binding by gonococcal TbpA deletion mu-
tants. To determine the functionality of the TbpA loop-dele-
tion mutants, we first tested the ability of strains expressing
deleted TbpAs to bind Tf in a solid-phase binding assay. As
shown in Fig. 3A, strains expressing TbpA loop deletions and
a functional TbpB (MCV201, MCV203, and MCV205) re-
tained Tf-binding capability as expected. In the absence of a
functional TbpB, strains MCV202 (DL5TbpA, TbpB2) and
MCV204 (DL4TbpA, TbpB2) were no longer competent for
Tf binding unlike their isogenic parent FA6905, which ex-
presses a full-length TbpA (Fig. 3A). MCV206 (DL8TbpA,
TbpB2) bound somewhat less Tf than did the wild-type strain
in the same assay (Fig. 3A), suggesting that this strain, while
capable of Tf binding, did so with diminished affinity or capac-
ity. Thus, deletion of either loop 4 or loop 5 prevented ligand
binding by TbpA and indicated that these regions contain
residues that are directly or indirectly required for Tf binding.
The apparent reduction of Tf binding to DL8TbpA suggested
that the presence loop 8 could be important for high-affinity
interactions between TbpA and its ligand.
Localization of gonococcal TbpA deletion mutants. The in-
ability of the loop 4 and loop 5 deletion mutants to bind Tf in
the solid-phase assay could have been the result of inappro-
priate processing or localization of the mutant proteins. To
address this possibility, duplicate whole-cell dot blots were
probed with a polyclonal anti-TbpA serum that recognized
surface-exposed TbpA. As shown in Fig. 3B, this serum bound
to all strains expressing either wild-type TbpA (FA19 and
FA6905) or mutated TbpAs (strains MCV201 to MCV206).
Strains FA6747 and FA6815 (both TbpA2) were not recog-
nized by this serum (Fig. 3B). These observations indicated
that wild-type TbpA and DL4TbpA, DL5TbpA, and DL8TbpA
were each surface exposed and accessible to antibody under
these conditions.
Since cell lysis could effect the apparent exposure of TbpA
and its deletion derivatives, we sought to confirm the dot blot
result of DL5TbpA using immunofluorescence microscopy, in
which the integrity of the reactive organisms could be assessed
by counterstain. As in the dot blot experiment, anti-TbpA
serum bound to whole, iron-stressed gonococci expressing
DL5TbpA, not to the isogenic tbpA mutant FA6747 (data not
shown). These results confirmed the results of the dot blot
(Fig. 3B), which indicated that this deleted version of TbpA
FIG. 1. Putative topology model of gonococcal TbpA. Horizontal dotted lines represent the planes of the gonococcal outer membrane. The predicted amphipathic
b-strands (22 in total) are shown in gray boxes. Putative surface exposed loops are numbered L1 to L11. Loops 4, 5, and 8 are indicated by red boxes, and the endpoints
of the DL4, DL5, and DL8 deletions are indicated by short horizontal black bars. Residues that are conserved among all 17 TbpAs sequenced to date (12) are indicated
by the squares. Residues that fall within previously characterized TonB homology domains (16) are shaded yellow. Residues that are variant among a panel of 5
gonococcal TbpAs (12) are shaded blue. Aromatic residues are circled. Cysteine residues are shaded orange. Two predicted trypsin cleavage sites are shaded pink.
Although the TbpA sequence contains many other predicted trypsin cleavage sites, cleavage at these two sites would generate proteolytic cleavage products that most
closely match the observed sizes of trypsin digest products T1 and T2 (see text). The sequences of three peptides used to generate antipeptide antibodies (12) are
highlighted in green.
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was surface exposed in iron-stressed gonococci, as was the
wild-type protein.
Liquid-phase Tf binding by gonococcal TbpA deletion mu-
tants. We used a liquid-phase Tf-binding assay to quantitate
the binding phenomena associated with the TbpA deletion
derivatives in the solid-phase binding assay. The curves shown
in Fig. 4 represent the amount of specific Tf bound as a func-
tion of Tf concentration, which ranged from 1.2 to 160 nM.
As in the solid-phase Tf binding assay, neither MCV204
(DL4TbpA, TbpB2) nor MCV202 (DL5TbpA, TbpB2) bound
any detectable Tf in this assay. In contrast, MCV206 (DL8TbpA,
TbpB2) bound Tf with nearly the same capacity as the wild-
type strain but with a much lower affinity. Whereas the wild-
type TbpA (expressed by FA6905 in the absence of TbpB)
bound Tf with a Kd of approximately 2.8 nM (Fig. 4 and ref-
erence 18), the DL8TbpA mutant bound Tf with a Kd of 22 nM.
The capacity of the wild-type and DL8TbpA mutant strain
were virtually indistinguishable, with copy numbers of 8.2 3
108 and 8.3 3 108 receptors/mg of total cell protein, respec-
tively. These data confirmed and extended the results of the
solid-phase Tf binding analysis, indicating that deletion of loop
4 or loop 5 prevented ligand binding completely, whereas de-
letion of loop 8 resulted in a 10-fold decrease in the affinity of
TbpA for Tf without affecting the copy number.
Growth of TbpA deletion mutants with transferrin as a sole
iron source. To assess the impact of TbpA mutagenesis on
Tf-iron utilization, strains MCV201 to MCV206 were plated
on minimal medium containing partially saturated Tf as the
sole iron source. As shown previously, the presence of TbpB
increases the efficiency of Tf-iron uptake but is not required for
growth on Tf as a sole iron source (2). All of the TbpA deletion
derivatives failed to grow on Tf, regardless of the presence of
a functional TbpB (Fig. 5), indicating that deletion of putative
loop 4 or 5 rendered TbpA unable to bind Tf and, despite
apparent surface exposure, unable to facilitate the uptake of
iron from Tf. Interestingly, DL8TbpA, which bound Tf with
lower affinity but equal capacity, did not facilitate iron inter-
nalization. All strains grew equally well on GC base medium
supplemented with Fe(NO3)3.
Protease accessibility of TbpA in deletion mutants. We pre-
viously identified energy-dependent conformational changes in
the Tf receptor based partly on the results of limited proteol-
ysis of whole, iron-stressed gonococci (14). Thus, we used
trypsin accessibility of the TbpA deletion derivatives as a mea-
sure of wild-type surface exposure and overall conformation.
When wild-type TbpA was exposed to low concentrations of
trypsin, two diagnostic products were generated, one with a
molecular mass of 95.2 kDa (T1) and the other with a molec-
ular mass of 54.9 kDa (T2) (Fig. 6A and reference 18). A
mutant TbpA lacking a functional TonB box (14) likewise
demonstrated a trypsin accessibility pattern characterized by
wild-type-sized T1 and T2 products (Fig. 6A). The deletion
derivatives of TbpA were universally accessible to exogenous
trypsin, a finding consistent with normal processing and surface
exposure of these proteins. The proteolytic fragments gener-
ated by trypsin digestion of the deletion derivatives did not
differ greatly in size from those generated by cleavage of the
wild-type protein, with T1 and T2 equivalents apparent in two
out of the three deletion mutants (Fig. 6A). The sizes of T1
and T2 equivalents in these mutants were consistent with the
number of amino acids that had been deleted in each con-
struct. In addition to T1 and T2, DL4TbpA spontaneously
proteolyzed, producing a detectable breakdown product at 0
min of trypsin exposure (Fig. 6A). This slight instability could
have resulted from deletion of most of a proposed membrane-
spanning b-strand (see Fig. 1) in this construct.
Trypsin digestion of DL5TbpA yielded a T1 equivalent but
TABLE 2. Oligonucleotides used in this study









a Mismatched bases, corresponding to mutagenic restriction sites, are shown in
boldface. The superscript “2” indicates an error incorporated into the oligonu-
cleotide.
FIG. 2. Construction of DL4TbpA. The 59 (striped) and 39 (gray) PCR-
amplified halves of tbpA were individually cloned into pCR2.1, which contains a
gene encoding ampicillin resistance (stippled bar). This procedure resulted in
plasmids pVCU206 and pVCU207, respectively. These inserts were excised and
ligated together in pET21 producing pVCU208, which contained DL4tbpA,
downstream of a T7 promoter (black bar). The position of the TbpA start codon
is shown as an open arrow, and that of the TbpA stop codon is marked with an
asterisk. Approximate positions of oligonucleotides are indicated by closed ar-
rows, with their respective names indicated in parentheses.
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no T2 equivalent. This was not surprising since the size of the
T2 product generated from the wild-type TbpA was consistent
with cleavage of an accessible trypsin site within putative loop
5 (T2 in Fig. 1), which had been deleted in this construct. To
confirm the mapping of this endpoint, we probed the wild-type
trypsin T2 cleavage product (data not shown) with a series of
antipeptide sera that have been previously described (12). The
T2 proteolytic product generated by wild-type TbpA digestion
was reactive in a Western blot with antiserum generated
against peptide TbpA-2 (Fig. 1) but was not reactive with sera
generated against peptides TbpA-5 and TbpA-6 (Fig. 1). Cu-
mulatively, these results indicated that the T2 product gener-
ated from wild-type TbpA contained the TbpA-2 peptide se-
quence but not the TbpA-5 or TbpA-6 peptide sequences (Fig.
1), therefore locating the carboxy-terminal endpoint of T2
between TbpA-2 and TbpA-5. In contrast to DL5TbpA, limited
proteolysis of DL8TbpA generated a T1 equivalent that was
smaller than the wild-type T1, consistent with the deletion of
loop 8, and a T2 equivalent that was identical in size to the
wild-type T2. These observations are consistent with our pro-
posed model in which the two accessible trypsin sites fall on
either side of putative loop 8.
Protease accessibility of TbpA in the presence of transferrin.
We have previously demonstrated that TbpA to which Tf is
bound is less accessible to exogenously added trypsin than
unliganded TbpA (18), while a de-energized, TonB-box mu-
tant of TbpA was almost completely inaccessible to trypsin in
the presence of ligand (14). As shown in Fig. 6B, the proteo-
lytic digestion patterns of DL4TbpA and DL5TbpA were un-
changed in the presence of Tf, whereas proteolysis of
DL8TbpA was inhibited in the presence of Tf, similar to wild-
type TbpA. These observations are consistent with our asser-
tion that neither DL4TbpA nor DL5TbpA bound Tf because
the presence of ligand did not effect the extent of proteolysis.
In contrast, since trypsin accessibility was inhibited by ligand
addition to DL8TbpA, we conclude that this derivative re-
tained Tf binding capabilities, an idea consistent with the re-
sults of Tf-binding assays (Fig. 3 and 4).
Protease accessibility of TbpB in gonococcal deletion mu-
tants. Previously, we demonstrated that TbpB is protected
from limited proteolysis only in the presence of an energized
TbpA (14). Thus, we analyzed the accessibility of TbpB to
trypsin in presence of the TbpA deletion derivatives to access
FIG. 3. Whole-cell, solid-phase Tf-binding assay. Whole, iron-stressed gonococci were spotted onto nitrocellulose filters and probed with HRP-Tf (A) or anti-TbpA
polyclonal serum (B). Numbering refers to the following gonococcal strains; 1, FA19 (wild type); 2, FA6905 (TbpA1 TbpB2); 3, FA6747 (TbpA2 TbpB1); 4, FA6815
(TbpA2 TbpB2); 5, MCV201 (DL5TbpA, TbpB1); 6, MCV202 (DL5TbpA, TbpB2); 7, MCV203 (DL4TbpA, TbpB1); 8, MCV204 (DL4TbpA, TbpB2); 9, MCV205
(DL8TbpA, TbpB1); and 10, MCV 206 (DL8TbpA, TbpB2). Images were scanned using a Hewlett-Packard ScanJet 6300c. Final images were annotated using Adobe
Photoshop 4.0.
FIG. 4. Equilibrium-phase Tf binding by TbpA deletion mutants. The plot
shows the amount of specifically bound Tf (in picograms bound per microgram
of total cell protein [TCP]) as a function of Tf concentration. }, Binding to
FA6905 (TbpA1 TbpB2); ■, binding to MCV206 (DL8TbpA, TbpB2); Œ, bind-
ing to MCV202 (DL5TbpA, TbpB2); F, binding to MCV204 (DL4TbpA,
TbpB2). The datum points are the means of three independent experiments.
Error bars indicate the standard deviations within each triplicate set.
FIG. 5. Growth of gonococcal strains using Tf as a sole iron source. Gono-
coccal strains were grown on CDM-agarose plates, supplemented with Tf (30%
iron saturated) as an iron source. Sector labeling refers to the following gono-
coccal strains: A, FA19 (wild type); B, FA6747 (TbpA2 TbpB1); C, FA6905
(TbpA1 TbpB2); D, FA6815 (TbpA2 TbpB2); E, MCV201 (DL5TbpA,
TbpB1); F, MCV202 (DL5TbpA, TbpB2); G, MCV203 (DL4TbpA, TbpB1); H,
MCV204 (DL4TbpA, TbpB2); I, MCV205 (DL8TbpA, TbpB1); and J, MCV 206
(DL8TbpA, TbpB2). Images were scanned using a Hewlett-Packard ScanJet
6300c. The final images were annotated using Adobe Photoshop 4.0.
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their ability to interact with and functionally protect TbpB
from trypsin. When coexpressed with DL4TbpA, DL5TbpA, or
DL8TbpA TbpB was protected at levels equivalent to those
observed with wild-type TbpA (data not shown), indicating
that the mutant TbpAs could interact with TbpB such that a
portion of the TbpB population was resistant to trypsin, similar
to the situation seen with the wild-type TbpA.
DISCUSSION
In this study, we propose a topological model of gonococcal
TbpA in which this protein forms an outer membrane pore
composed of 22 transmembrane b-strands. In addition, we
suggest that gonococcal TbpA has a periplasmic globular do-
main, one similar to that identified in the crystal structures of
two other TonB-dependent receptors, FepA (8) and FhuA
(35). The authors of those studies hypothesized that the glob-
ular domain serves as a “plug” (35) or “hatch” (8) that oc-
cludes the lumen of the b-barrel formed by other transmem-
brane b-strands. Given the extent of conservation between
TbpA and the TonB-dependent receptors and also the relative
lack of divergence among neisserial TbpA sequences in this
region (12), we suggest that this domain may have a similar
location and function in gonococcal TbpA. The large size,
structural complexity, and dynamic nature of both TbpA (14)
and Tf (50), suggest that multiple surface-exposed epitopes
may determine the ligand-binding characteristics of this recep-
tor. Thus, our proposed topological model includes 11 putative
loops, any or all of which could include ligand-binding do-
mains.
In the current study, we determined the phenotypes of mu-
tant gonococcal strains expressing TbpAs deleted of putative
loop 4, 5, or 8. These mutant proteins were expressed from the
gonococcal chromosome without apparent toxicity or inhibi-
tion of bacterial growth. Using solid- and liquid-phase Tf-
binding assays, immunoblots, protease accessibility, and TbpB
interaction, we confirmed the outer membrane localization of
each mutant protein. Extreme structural perturbation of outer
membrane proteins typically results in aberrant localization,
spontaneous proteolysis and, in some cases, inviability (41, 42).
In the absence of these effects, we conclude that the native
conformation adopted by wild-type TbpA was broadly con-
served among the mutants characterized in this study. The sole
exception to this overall conclusion is DL4TbpA, which exhib-
ited slight proteolytic instability and therefore native folding
might have been effected by deletion of most of proposed
b-strand 8 in addition to loop 4. However, as evaluated by the
trypsin accessibility pattern of TbpA expressed by this mutant,
a large portion of the deleted protein was exported to the
surface in a conformation similar to that of wild-type TbpA.
The DL5TbpA protein was apparently surface exposed and
resulted in no spontaneous breakdown products, suggesting
FIG. 6. Trypsin accessibility of mutant TbpAs in the presence and absence of ligand. (A) Whole, iron-stressed cells from the indicated gonococcal strains were
treated with trypsin (0.5 mg/ml) for 0 min (lane 1), 10 min (lane 2), 20 min (lane 3), or 30 min (lane 4) as indicated above each panel. Whole-cell lysates were prepared
from the trypsinized cells, and the proteins were separated by SDS-PAGE. The resulting Western blots were probed with polyclonal anti-TbpA serum (16). (B) Whole,
iron-stressed cells from the indicated gonococcal strains were exposed to 100 nM iron-saturated Tf and then treated with trypsin (0.5 mg/ml) for 0 min (lane 1), 10 min
(lane 2), 20 min (lane 3), or 30 min (lane 4) as indicated above each panel. The resulting Western blots were probed with polyclonal anti-TbpA serum (16). The labels
T1 and T2 on the left of each panel indicate the positions of two characteristic products that resulted from limited proteolysis of TbpA. Approximate positions of
molecular mass standards are indicated in kilodaltons on the right of each panel. Images were scanned using a Hewlett-Packard ScanJet 6300c. The final images were
annotated using Adobe Photoshop 4.0.
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that deletion of this putative loop did not negatively impact
protein export. Likewise, the observation of nearly identical
numbers of DL8TbpA receptors relative to the wild-type re-
ceptor in whole-cell, liquid-phase Tf-binding assays indicates
that deletion of these loops had no discernible deleterious
effects on protein export or surface exposure. Therefore, we
suggest that the alteration in Tf binding by these mutants
resulted from the deletion of functionally significant epitopes
rather than from gross conformational disruption or reduced
surface exposure.
Deletion of loop 4 or loop 5 resulted in mutant versions of
TbpA that were incapable of Tf binding and that did not
support growth on Tf-bound iron, suggesting that these puta-
tive loops are critical for ligand interaction and subsequent
iron internalization. Even in the presence of a functional
TbpB, iron utilization was prevented by deletion of loop 4 or
loop 5 from TbpA, indicating that the mere proximity of fer-
rated Tf (bound to TbpB) was insufficient to allow iron uptake.
Deletion of loop 8 from TbpA resulted in a mutant that was
capable of binding Tf with a 10-fold decreased affinity relative
to wild-type TbpA. However, this deletion mutant was ren-
dered completely incompetent for Tf-iron internalization.
These observations suggest that intimate, high-affinity interac-
tions between TbpA and Tf are required for iron removal and
subsequent iron transport through the outer membrane.
Limited proteolysis has been used to identify flexible do-
mains in globular enzymes (24) and as a probe of conforma-
tional change in soluble proteins (20). In this study, we used
accessibility to exogenous protease as a measure of surface
exposure and overall membrane topology in the TbpA deletion
derivatives. We have previously shown that exposure of sur-
face-exposed TbpA to low concentrations of trypsin produced
two diagnostic proteolytic products (18). Although mature
TbpA contains 129 predicted trypsin cleavage sites, only two
are readily accessible in the membrane-bound, surface-ex-
posed protein. Since protease accessibility is correlated with
unstructured, highly flexible, hinge regions (24), we suggest
that the trypsin cleavage sites in TbpA might reflect structur-
ally important features of the receptor. The measured size of
the largest wild-type proteolytic digestion product (T1) most
closely corresponds to a peptide that spans from the mature
amino terminus to Arg857, located in putative loop 11. The
size of the T2 proteolytic product corresponds in size to a
peptide that spans from the mature amino terminus to Arg498,
located in putative loop 5. Thus, these regions are predicted to
be sufficiently flexible to allow protease cleavage, and might
represent hinge regions separating structurally constrained do-
mains.
When we applied the protease susceptibility analysis to the
deletion derivatives of TbpA, similarly sized proteolytic prod-
ucts were generated, indicating that the gross topological fea-
tures of the mutant TbpAs were similar to those expressed by
the wild-type strain. Both T1 and T2 equivalents produced by
trypsin cleavage of DL4TbpA were proportionally smaller than
their wild-type counterparts, which is consistent with deletion
of loop 4. Only a T1 equivalent was generated by trypsin
digestion of DL5TbpA, which is consistent with the concomi-
tant deletion of the accessible trypsin site (Arg498) in loop 5.
Of the two proteolytic digestion products generated from
DL8TbpA, the T1 equivalent was proportionally smaller by the
size of the loop 8 deletion, but the T2 product was wild-type
sized. From this analysis, we conclude that putative loop 8 is
located between the two accessible trypsin sites that generated
T1 and T2.
We have previously shown that by binding Tf prior to trypsin
treatment, the accessibility of TbpA to the protease is inhibited
(14, 18). In mutants in which TbpA is de-energized by Ton
system defects, TbpA is almost completely protected from pro-
teolysis, suggesting that TonB-derived energy is required for Tf
release from the receptor (14). We analyzed the loop deletion
mutants for their trypsin accessibility following ligand binding
and found that, unlike a de-energized TbpA, all were accessi-
ble to trypsin. However, DL8TbpA was protected by the pres-
ence of ligand to an extent similar to that in wild-type TbpA, a
finding consistent with the Tf-binding capabilities of this mu-
tant. Unlike DL8TbpA, mutants DL4TbpA and DL5TbpA
were equally susceptible to trypsin cleavage in the presence or
absence of ligand, a result consistent with their complete in-
ability to bind Tf.
In a similar analysis, we found that TbpB was protected from
exogenous trypsin when coexpressed with either wild-type (14,
18) or mutant TbpA. Using this protease-resistant character-
istic of TbpB, we developed a model of energy-dependent,
conformational change or complex formation between TbpA
and TbpB (14). Because the deletion mutants described in this
study protect coexpressed TbpB from trypsin in a manner
similar to that seen with wild-type TbpA, we conclude that on
whole, iron-stressed gonococci, TbpA and TbpB formed a
transient, energy-dependent complex similar to that detected
in the wild-type strain. This implies that, under these condi-
tions, the deleted regions were not essential for the preserva-
tion of physical proximity between TbpA and TbpB or for their
proposed energy-dependent interaction.
Since expression of the Tf receptor is required to initiate
infection in a human challenge model of gonococcal infection
(17), identification of domains of TbpA that are necessary for
the optimal function of this receptor could lead to therapies or
prevention strategies aimed at abrogating its function. Thus,
loops 4 and 5, which are essential for optimal ligand binding,
could constitute novel targets for immunoprophylaxis against
gonococcal disease. Alternatively, inhibitors of transferrin
binding by these loops might serve as a mode of therapy
against an already established infection. Loop 8, which appears
to play a more subtle role in Tf binding but nevertheless crit-
ically impacts Tf-iron utilization, may also warrant assessment
as a candidate vaccine antigen or target of inhibition. We are
currently constructing smaller deletions and point mutations to
further characterize the complex ligand binding and interactive
properties of gonococcal TbpA.
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